DANIEL P. GOLD, PH.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

MEI Pharma, Inc.

Filing Date Source Excerpt
2013-10-18 Dr. Gold received a Bachelor's degree in biology from University of California Los Angeles and received a Doctorate degree from Tufts University in Pathology/Immunology.
2014-10-17 Dr. Gold received a Bachelor's degree in biology from University of California Los Angeles and received a Doctorate degree from Tufts University in Pathology/Immunology.
2015-10-16 Dr. Gold received a Bachelor’s degree in biology from University of California Los Angeles and received a Doctorate degree in Pathology/Immunology from Tufts University.
2016-10-17 Dr. Gold holds a Ph.D. in Pathology/Immunology from Tufts University, Boston and a bachelor’s degree in Biology from the University of California Los Angeles.
2017-10-16 Dr. Gold's academic qualifications include Postdoctoral Fellowships at the Dana-Farber Cancer Institute, at the Harvard School of Medicine and the Massachusetts Institute of Technology, Center for Cancer Research. He holds a Ph.D. in Pathology/Immunology from Tufts University, Boston and a bachelor's degree in Biology from the University of California Los Angeles.
2018-10-11 He holds a Ph.D. in Pathology/Immunology from Tufts University, Boston and a bachelor’s degree in Biology from the University of California Los Angeles.
2019-10-23 Dr. Gold holds a Ph.D. in Pathology/Immunology from Tufts University, Boston and a bachelor’s degree in Biology from the University of California Los Angeles.
2020-10-27 Dr. Gold holds a Ph.D. in Pathology/Immunology from Tufts University, Boston and a bachelor’s degree in Biology from the University of California Los Angeles.
2021-10-28 Dr. Gold holds a Ph.D. in Pathology/Immunology from Tufts University and a bachelor’s degree in Biology from the University of California, Los Angeles. He has extensive experience in drug discovery and development.
2022-10-27 Dr. Gold’s academic qualifications include Postdoctoral Fellowships at the Dana-Farber Cancer Institute, at the Harvard School of Medicine and the Massachusetts Institute of Technology, Center for Cancer Research. He holds a Ph.D. in Pathology/Immunology from Tufts University, Boston and a bachelor’s degree in Biology from the University of California, Los Angeles.

Data sourced from SEC filings. Last updated: 2026-02-03